https://orcid.org/0000-0002-0212-3624
References
- Liu H, Xing Y, Nie Q, et al. Association between sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:2153–2163. doi:10.2147/DMSO.S420872
- Ludgate M, Emerson CH. Metamorphic thyroid autoimmunity. Thyroid. 2008;18(10):1035–1037. doi:10.1089/thy.2008.1551
- Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429–443. doi:10.1038/s41577-021-00639-3
- Barchetta I, Agata Cimini F, Gisella Cavallo M. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): an update. Nutrients. 2020;12(11):3302. doi:10.3390/nu12113302
- Bai K, Dong H, Liu L, et al. Serum 25-hydroxyvitamin D status of a large Chinese population from 30 provinces by LC-MS/MS measurement for consecutive 3 years: differences by age, sex, season and province. Eur J Nutr. 2023;62(3):1503–1516. doi:10.1007/s00394-023-03094-z